$NAHD
New Asia Holdings Inc

2024 Q2 Form 10-K Financial Statement

#000109690624001168 Filed on May 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $11.72K $56.02K $100.7K
YoY Change -53.92% 70.27% -2.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $70.78K $56.02K $195.0K
YoY Change 57.09% 70.27% 26.59%
Operating Profit -$70.78K -$195.0K
YoY Change 57.09% 26.59%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $7.500K
YoY Change
Pretax Income -$70.78K -$48.52K -$187.5K
YoY Change 57.09% 47.48% 21.72%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$70.78K -$48.52K -$187.5K
YoY Change 57.09% 47.48% 21.72%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 75.29M shares 75.29M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.880K $1.880K
YoY Change -80.87% -80.87%
Cash & Equivalents $13.39K $1.883K
Short-Term Investments
Other Short-Term Assets $13.75K $13.75K
YoY Change 5.44% 5.44%
Inventory
Prepaid Expenses $6.438K $13.75K
Receivables
Other Receivables
Total Short-Term Assets $19.83K $15.63K $15.63K
YoY Change -32.4% -31.64% -31.66%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.00 $200.00
YoY Change 0.0% 0.0%
Total Long-Term Assets $195.00 $195.00 $200.00
YoY Change 0.0% 0.0% 5.26%
TOTAL ASSETS
Total Short-Term Assets $19.83K $15.63K $15.63K
Total Long-Term Assets $195.00 $195.00 $200.00
Total Assets $20.03K $15.83K $15.83K
YoY Change -32.18% -31.37% -31.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $329.8K $329.8K
YoY Change 32.56% 32.56%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.474M $1.359M $1.359M
YoY Change 14.52% 13.73% 13.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.474M $1.359M $1.359M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.474M $1.359M $1.359M
YoY Change 14.52% 13.73% 13.73%
SHAREHOLDERS EQUITY
Retained Earnings -$12.94M -$12.83M
YoY Change 1.54% 1.48%
Common Stock $75.29K $75.29K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.454M -$1.343M -$1.343M
YoY Change
Total Liabilities & Shareholders Equity $20.03K $15.83K $15.83K
YoY Change -32.18% -31.37% -31.35%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$70.78K -$48.52K -$187.5K
YoY Change 57.09% 47.48% 21.72%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$37.69K -$90.75K
YoY Change 24.1% 17.66%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 19.00K $83.00K
YoY Change -22.45% 183.74%
NET CHANGE
Cash From Operating Activities -37.69K -$90.75K
Cash From Investing Activities
Cash From Financing Activities 19.00K $83.00K
Net Change In Cash -18.69K -$7.750K
YoY Change 218.4% -83.81%
FREE CASH FLOW
Cash From Operating Activities -$37.69K -$90.75K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-55410
CY2023 dei Entity Registrant Name
EntityRegistrantName
New Asia Holdings, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-0460095
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
80 Tras Street
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
#01-03
CY2023 dei Entity Address Country
EntityAddressCountry
SG
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Singapore
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
079019
CY2023 dei Country Region
CountryRegion
65
CY2023 dei City Area Code
CityAreaCode
6820
CY2023 dei Local Phone Number
LocalPhoneNumber
8885
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
2298904 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75288667 shares
CY2023 dei Auditor Firm
AuditorFirmId
5854
CY2023 dei Auditor Name
AuditorName
TAAD LLP
CY2023 dei Auditor Location
AuditorLocation
Diamond Bar, California
CY2023Q4 us-gaap Cash
Cash
1883 usd
CY2022Q4 us-gaap Cash
Cash
9833 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
0 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
0 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13750 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13035 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
15633 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
22868 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
195 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
195 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
195 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
195 usd
CY2023Q4 us-gaap Assets
Assets
15828 usd
CY2022Q4 us-gaap Assets
Assets
23063 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
57483 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
248797 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
272343 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
0 usd
CY2023Q4 fil Advance From Shareholder
AdvanceFromShareholder
1028704 usd
CY2022Q4 fil Advance From Shareholder
AdvanceFromShareholder
945704 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1358530 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1194501 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1358530 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1194501 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75288667 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75288667 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75288667 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75288667 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
75289 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
75289 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11416188 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11399713 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12833573 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12646034 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-606 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-406 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1342702 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1171438 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15828 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23063 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
94373 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
50381 usd
CY2023 us-gaap Selling Expense
SellingExpense
33716 usd
CY2022 us-gaap Selling Expense
SellingExpense
34900 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
66950 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68789 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
195039 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
154070 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-195039 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-154070 usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7500 usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-187539 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-154070 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-187539 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-154070 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-200 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-177 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-187739 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-154247 usd
CY2023 fil Net Loss Per Common Share Basic And Fully Diluted
NetLossPerCommonShareBasicAndFullyDiluted
-0
CY2022 fil Net Loss Per Common Share Basic And Fully Diluted
NetLossPerCommonShareBasicAndFullyDiluted
-0
CY2023 fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
75288667 shares
CY2022 fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
75288667 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1017191 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-177 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-154070 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1171438 usd
CY2023 fil Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
16475 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-200 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-187539 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1342702 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-187539 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-154070 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
715 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1098 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
36522 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
75842 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
60982 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90750 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-77130 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
83000 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
32500 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
3248 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
83000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29252 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-200 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-177 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7950 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-48055 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9833 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57888 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1883 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9833 usd
CY2023 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Interest Paid
InterestPaid
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
800 usd
CY2023 fil Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
16475 usd
CY2022 fil Settlement Of Liabilities With A Related Party
SettlementOfLiabilitiesWithARelatedParty
0 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;text-align:justify">Use of Estimates</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.</p>
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2631509 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12700000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
187539 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
154070 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
187539 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
154070 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2670892 usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2631509 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2670892 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022 us-gaap Increase Decrease In Due To Officers And Stockholders
IncreaseDecreaseInDueToOfficersAndStockholders
83000 usd
CY2023 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-3248 usd
CY2023Q4 fil Other Income Cancelled Debt
OtherIncomeCancelledDebt
1028704 usd
CY2022Q4 fil Other Income Cancelled Debt
OtherIncomeCancelledDebt
945704 usd
CY2023Q4 fil Other Income Cancelled Debt
OtherIncomeCancelledDebt
1028704 usd

Files In Submission

Name View Source Status
0001096906-24-001168-index-headers.html Edgar Link pending
0001096906-24-001168-index.html Edgar Link pending
0001096906-24-001168.txt Edgar Link pending
0001096906-24-001168-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nahd-20231231.htm Edgar Link pending
nahd-20231231.xsd Edgar Link pending
nahd10k_1.jpg Edgar Link pending
nahd10k_2.jpg Edgar Link pending
nahd10k_3.jpg Edgar Link pending
nahd_ex31z1.htm Edgar Link pending
nahd_ex31z2.htm Edgar Link pending
nahd_ex32z1.htm Edgar Link pending
nahd_ex4z1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nahd-20231231_cal.xml Edgar Link unprocessable
nahd-20231231_def.xml Edgar Link unprocessable
nahd-20231231_lab.xml Edgar Link unprocessable
nahd-20231231_pre.xml Edgar Link unprocessable
nahd-20231231_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending